Efficiency Adjustment Delay Act
Summary
HR7520 delays a scheduled Medicare physician fee schedule efficiency adjustment until 2030, preserving current payment rates. This is a near-term positive for healthcare providers and Medicare Advantage insurers, preventing cuts that would have reduced revenue. The bill is early in the legislative process, so upside is not guaranteed, but the delay protects billions in Medicare payments.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7520 delays Medicare physician payment cuts, supporting hospital and provider revenue.
- 2.Preserves ~$2-5B in annual Medicare spending that would have been cut.
- 3.Beneficiaries: acute care hospitals, dialysis providers, labs, Medicare Advantage insurers.
- 4.Early-stage bill with bipartisan sponsorship; legislative path remains long.
Market Implications
The bill's delay of Medicare physician payment cuts is a positive for healthcare services stocks. HCA, UHS, DVA, DGX, LH, UNH, and HUM all have significant exposure to Medicare revenue. If the bill gains momentum, these stocks could see relative outperformance. However, the early-stage nature limits immediate catalysts. Investors should monitor committee markups and CBO score.
Full Analysis
The 'Efficiency Adjustment Delay Act' (HR7520) was introduced by Rep. Estes (R-KS) on February 12, 2026, and referred to the Energy and Commerce and Ways and Means committees. The bill delays implementation of a CMS efficiency adjustment to work Relative Value Units (RVUs) under the Medicare Physician Fee Schedule until January 1, 2030. The adjustment, originally set to phase in earlier, would have reduced payment rates for physician services. By delaying, the bill maintains current higher reimbursement levels.
This is an authorization-only bill—it does not appropriate funds, but it prevents reductions in existing spending. The Congressional Budget Office would likely score this as increasing mandatory spending (or reducing savings). The bill has 12 cosponsors and is early-stage; it requires committee action, floor votes, and Senate passage.
The money trail: Medicare Physician Fee Schedule payments are a major funding stream for hospitals, physician groups, and labs. Medicare paid ~$90B under the fee schedule in 2025. The adjustment would have reduced rates by an estimated 2-5% over several years. Delaying that preserves roughly $2-5B annually across the system. Private insurers also benefit indirectly because Medicare Advantage benchmarks are tied to fee-for-service costs.
Structural winners: Acute care hospitals (HCA, UHS) with high Medicare exposure; dialysis providers (DVA) reliant on nephrologist referrals; diagnostic labs (DGX, LH) whose professional component payments are tied to the fee schedule; and Medicare Advantage plans (UNH, HUM) that benefit from higher benchmark rates. Losers are minimal; the bill simply maintains status quo. However, some budget hawks may oppose the revenue loss.
Timeline: Next steps include markup in one or both committees, House floor vote, Senate consideration. Given bipartisan interest (cosponsor Suozzi is a Democrat), passage odds are moderate but uncertain in a divided Congress.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Delays implementation of an efficiency adjustment to work relative value units under the Medicare physician fee schedule until 2030, maintaining current higher payment rates for physician services.
Who must act
Centers for Medicare & Medicaid Services (CMS)
What happens
Medicare physician payment rates remain at current levels instead of being reduced by the efficiency adjustment, increasing Medicare reimbursement for physician services provided by hospitals and affiliated physicians.
Stock impact
HCA Healthcare's hospital-based physician services and outpatient departments receive higher Medicare payments, boosting revenue. Medicare accounts for ~30% of HCA's revenue; a typical 5-10% cut avoided could preserve $200-400M annually.
What the bill does
Delays implementation of an efficiency adjustment to work relative value units under the Medicare physician fee schedule until 2030, maintaining current higher payment rates for physician services.
Who must act
Centers for Medicare & Medicaid Services (CMS)
What happens
Medicare physician payment rates remain at current levels instead of being reduced, increasing reimbursement for physician services provided by UHS acute care hospitals.
Stock impact
Universal Health Services' acute care hospitals benefit from stable Medicare physician payment rates. Medicare accounts for ~28% of UHS revenue; avoiding a cut preserves an estimated $50-100M annually.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Our Doctors First Act of 2026
Train More Nurses Act
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".
Patients Deserve Price Tags Act
Health Marketplace and Savings Accounts for All Act
Protecting Seniors and Stopping Fraudsters Act
To amend title XVIII of the Social Security Act to establish coverage for certain residential substance use disorder services under the Medicare program.
Improving Seniors’ Timely Access to Care Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →